In the KEGG results (Figure 2F), several pathways were found to be potentially involved, such as lipid and atherosclerosis, AGE-RAGE signaling pathway in diabetic complications, insulin resistance, and AMPK signaling pathway, suggesting that these pathways are related to the underlying mechanisms of ECD in relieving NAFLD and IR. This evidence concerns the gene RENBP and metabolic dysfunction-associated steatotic liver disease.